Dr Helen Edelberg is Head of Med Safety Assmt for Innovative Med & Gbl Safety Risk Mgmt, which provides authoritative expertise on development & execution of rigorous & innovative risk mgmt strategies at BMS. A strategic & innovative biopharmaceutical exec & physician with ~20 years Reg/PV & academic med/clin practice experience, she has presented on devt & implementation of best practices to accelerate product devt, approval & ongoing benefit-risk evaluation in a variety of settings.